Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28847255 | 0.98 | TSHR (0.50) | TSHRCYP3A4ALOX15ALDH1A1SMN1; SMN2 | |
| SCHEMBL164458 | 0.82 | TSHR (0.52) | TSHRCYP3A4ALOX15ALDH1A1SMN1; SMN2 | |
| SCHEMBL29462390 | 0.82 | TSHR (0.52) | TSHRCYP3A4ALOX15ALDH1A1SMN1; SMN2 | |
| SCHEMBL7050401 | 0.78 | MAOA (0.61) | CYP3A4ALDH1A1TDP1VCAM1HPGD | |
| SCHEMBL31441456 | 0.78 | MAOA (0.61) | CYP3A4ALDH1A1TDP1VCAM1HPGD | |
| SCHEMBL29137848 | 0.77 | TSHR (0.52) | TSHRCYP3A4ALOX15ALDH1A1SMN1; SMN2 | |
| SCHEMBL6146245 | 0.77 | TSHR (0.52) | TSHRCYP3A4ALOX15ALDH1A1SMN1; SMN2 | |
| SCHEMBL2028221 | 0.76 | KDM4E (0.55) | TSHRCYP3A4ALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL5070146 | 0.76 | MEN1 (0.48) | TSHRCYP3A4ALOX15ALDH1A1SMN1; SMN2 | |
| SCHEMBL30799696 | 0.76 | KDM4E (0.55) | TSHRCYP3A4ALDH1A1SMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 487 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119176746-B | Method for preparing bisphenol A and heterocyclic compound by using waste PC | 浙江大学 | 2025-05-30 | — | — | CN | claimed |
| CN-119176746-A | Method for preparing bisphenol A and heterocyclic compound by using waste PC | 浙江大学 | 2024-12-24 | — | — | CN | claimed |
| CN-118440013-A | Preparation method of quinazoline diketone compound | 安顺学院 | 2024-08-06 | — | — | CN | claimed |
| CN-114380718-B | Acylation method of aniline compound | 河南农业大学 | 2022-09-30 | — | — | CN | claimed |
| CN-114380718-A | Acylation method of aniline compound | 河南农业大学 | 2022-04-22 | — | — | CN | claimed |
| CN-109232366-B | Preparation method and application of 2-acyl-3-aminoindole compound | 华中师范大学 | 2020-08-21 | — | — | CN | claimed |
| CN-106946800-B | A kind of synthetic method of -2,4 (1H, 3H)-diketone of quinazoline and its derivative | 华东师范大学 | 2019-11-15 | — | — | CN | claimed |
| CN-109232366-A | The preparation method and applications of 2- acyl group -3- amino indole class compound | 华中师范大学 | 2019-01-18 | — | — | CN | claimed |
| CN-106946800-A | A kind of synthetic method of (1H, the 3H) diketone of quinazoline 2,4 and its derivative | 华东师范大学 | 2017-07-14 | — | — | CN | claimed |
| US-7759390-B2 | chemokine receptor 9(CCR9) antagonists such as, 5-Chloro-thiophene-2-sulfonic acid (4-cyano-2-methyl-phenyl)-amide, used for treating autimmune and inflammatory diseases, transplantat rejection and cancer | NOVARTIS AG (CH) | 2010-07-20 | — | — | US | claimed |
| US-7547713-B2 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2009-06-16 | — | — | US | claimed |
| US-20080300295-A1 | Inhibitors of Ccr9 Activity | NOVARTIS AG (CH) | 2008-12-04 | — | — | US | claimed |
| EP-1966182-A1 | INHIBITORS OF CCR9 ACTIVITY | Novartis AG (CH) | 2008-09-10 | — | — | EP | claimed |
| WO-2007071440-A1 | INHIBITORS OF CCR9 ACTIVITY | NOVARTIS AG (CH) | 2007-06-28 | — | — | WO | claimed |
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2006-05-25 | — | — | US | claimed |
| US-4288362-A | Monoazo pigments containing a quinazo linonylacetoacetanilide coupling component | BAYER AKTIENGESELLSCHAFT (DE) | 1981-09-08 | — | — | US | claimed |
| US-12552772-B2 | 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD | SPRINGWORKS THERAPEUTICS, INC. (US) | 2026-02-17 | — | — | US | disclosed |
| US-12540248-B2 | Metal surface-treating agent, and metal material with coating film and method for manufacturing same | NIHON PARKERIZING CO., LTD. (JP) | 2026-02-03 | — | — | US | disclosed |
| US-3987192-A | ANTIALLERGENS AND ANTIANAPHYLAXID; 2'-CYANO-OXANILIC ACID | THE UPJOHN COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
| US-3956264-A | Basic azo dyestuffs having indolyl-methyleneamino substituent in the diazo component | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540248-B2 | Metal surface-treating agent, and metal material with coating film and method for manufacturing same | VMA21, CARM1, CROCC | TSHR 1756/4885CYP3A4 3843/4885ALOX15 2760/4885 |
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | PTGS2, PTGES2, PTGES | TSHR 4772/4885CYP3A4 32/4885ALOX15 227/4885 |
| US-20080300295-A1 | Inhibitors of Ccr9 Activity | CCR9, CCR1, CCR4 | TSHR 1137/4885CYP3A4 842/4885ALOX15 2570/4885 |
| US-12552772-B2 | 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD | YAP1, TEAD3, TEAD2 | TSHR 1671/4885CYP3A4 3463/4885ALOX15 3142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.